Abstract
Summary
LPI (LP Information)' newest research report, the “Orlistat API Industry Forecast” looks at past sales and reviews total world Orlistat API sales in 2022, providing a comprehensive analysis by region and market sector of projected Orlistat API sales for 2023 through 2029. With Orlistat API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orlistat API industry.
This Insight Report provides a comprehensive analysis of the global Orlistat API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orlistat API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orlistat API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orlistat API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orlistat API.
The global Orlistat API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orlistat API players cover Lunan Pharmaceutical Group, NEWEDGE Overseas, AASraw Biochemical Technology, Aspire Lifesciences, Credo Life Sciences, Formosa Laboratories, GPT Pharmaceuticals, Grand Health Industrial and Hanways Chempharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orlistat API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.98
0.99
0.999
Others
Segmentation by application
Capsules
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lunan Pharmaceutical Group
NEWEDGE Overseas
AASraw Biochemical Technology
Aspire Lifesciences
Credo Life Sciences
Formosa Laboratories
GPT Pharmaceuticals
Grand Health Industrial
Hanways Chempharm
Hasti Aria Shimi
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1)
Mcneil and Argus pharmaceutical
Meenaxy Pharma
Murli Krishna Pharma
Pellets Pharma Limited
Qualitek pharma
Spansules Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orlistat API market?
What factors are driving Orlistat API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orlistat API market opportunities vary by end market size?
How does Orlistat API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Orlistat API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orlistat API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orlistat API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orlistat API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orlistat API.
The global Orlistat API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orlistat API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orlistat API players cover Lunan Pharmaceutical Group, NEWEDGE Overseas, AASraw Biochemical Technology, Aspire Lifesciences, Credo Life Sciences, Formosa Laboratories, GPT Pharmaceuticals, Grand Health Industrial and Hanways Chempharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Orlistat API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.98
0.99
0.999
Others
Segmentation by application
Capsules
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lunan Pharmaceutical Group
NEWEDGE Overseas
AASraw Biochemical Technology
Aspire Lifesciences
Credo Life Sciences
Formosa Laboratories
GPT Pharmaceuticals
Grand Health Industrial
Hanways Chempharm
Hasti Aria Shimi
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1)
Mcneil and Argus pharmaceutical
Meenaxy Pharma
Murli Krishna Pharma
Pellets Pharma Limited
Qualitek pharma
Spansules Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orlistat API market?
What factors are driving Orlistat API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orlistat API market opportunities vary by end market size?
How does Orlistat API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orlistat API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Orlistat API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Orlistat API by Country/Region, 2018, 2022 & 2029
2.2 Orlistat API Segment by Type
2.2.1 0.98
2.2.2 0.99
2.2.3 0.999
2.2.4 Others
2.3 Orlistat API Sales by Type
2.3.1 Global Orlistat API Sales Market Share by Type (2018-2023)
2.3.2 Global Orlistat API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Orlistat API Sale Price by Type (2018-2023)
2.4 Orlistat API Segment by Application
2.4.1 Capsules
2.4.2 Others
2.5 Orlistat API Sales by Application
2.5.1 Global Orlistat API Sale Market Share by Application (2018-2023)
2.5.2 Global Orlistat API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Orlistat API Sale Price by Application (2018-2023)
3 Global Orlistat API by Company
3.1 Global Orlistat API Breakdown Data by Company
3.1.1 Global Orlistat API Annual Sales by Company (2018-2023)
3.1.2 Global Orlistat API Sales Market Share by Company (2018-2023)
3.2 Global Orlistat API Annual Revenue by Company (2018-2023)
3.2.1 Global Orlistat API Revenue by Company (2018-2023)
3.2.2 Global Orlistat API Revenue Market Share by Company (2018-2023)
3.3 Global Orlistat API Sale Price by Company
3.4 Key Manufacturers Orlistat API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orlistat API Product Location Distribution
3.4.2 Players Orlistat API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Orlistat API by Geographic Region
4.1 World Historic Orlistat API Market Size by Geographic Region (2018-2023)
4.1.1 Global Orlistat API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Orlistat API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Orlistat API Market Size by Country/Region (2018-2023)
4.2.1 Global Orlistat API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Orlistat API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Orlistat API Sales Growth
4.4 APAC Orlistat API Sales Growth
4.5 Europe Orlistat API Sales Growth
4.6 Middle East & Africa Orlistat API Sales Growth
5 Americas
5.1 Americas Orlistat API Sales by Country
5.1.1 Americas Orlistat API Sales by Country (2018-2023)
5.1.2 Americas Orlistat API Revenue by Country (2018-2023)
5.2 Americas Orlistat API Sales by Type
5.3 Americas Orlistat API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orlistat API Sales by Region
6.1.1 APAC Orlistat API Sales by Region (2018-2023)
6.1.2 APAC Orlistat API Revenue by Region (2018-2023)
6.2 APAC Orlistat API Sales by Type
6.3 APAC Orlistat API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Orlistat API by Country
7.1.1 Europe Orlistat API Sales by Country (2018-2023)
7.1.2 Europe Orlistat API Revenue by Country (2018-2023)
7.2 Europe Orlistat API Sales by Type
7.3 Europe Orlistat API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orlistat API by Country
8.1.1 Middle East & Africa Orlistat API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Orlistat API Revenue by Country (2018-2023)
8.2 Middle East & Africa Orlistat API Sales by Type
8.3 Middle East & Africa Orlistat API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orlistat API
10.3 Manufacturing Process Analysis of Orlistat API
10.4 Industry Chain Structure of Orlistat API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orlistat API Distributors
11.3 Orlistat API Customer
12 World Forecast Review for Orlistat API by Geographic Region
12.1 Global Orlistat API Market Size Forecast by Region
12.1.1 Global Orlistat API Forecast by Region (2024-2029)
12.1.2 Global Orlistat API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orlistat API Forecast by Type
12.7 Global Orlistat API Forecast by Application
13 Key Players Analysis
13.1 Lunan Pharmaceutical Group
13.1.1 Lunan Pharmaceutical Group Company Information
13.1.2 Lunan Pharmaceutical Group Orlistat API Product Portfolios and Specifications
13.1.3 Lunan Pharmaceutical Group Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Lunan Pharmaceutical Group Main Business Overview
13.1.5 Lunan Pharmaceutical Group Latest Developments
13.2 NEWEDGE Overseas
13.2.1 NEWEDGE Overseas Company Information
13.2.2 NEWEDGE Overseas Orlistat API Product Portfolios and Specifications
13.2.3 NEWEDGE Overseas Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 NEWEDGE Overseas Main Business Overview
13.2.5 NEWEDGE Overseas Latest Developments
13.3 AASraw Biochemical Technology
13.3.1 AASraw Biochemical Technology Company Information
13.3.2 AASraw Biochemical Technology Orlistat API Product Portfolios and Specifications
13.3.3 AASraw Biochemical Technology Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AASraw Biochemical Technology Main Business Overview
13.3.5 AASraw Biochemical Technology Latest Developments
13.4 Aspire Lifesciences
13.4.1 Aspire Lifesciences Company Information
13.4.2 Aspire Lifesciences Orlistat API Product Portfolios and Specifications
13.4.3 Aspire Lifesciences Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aspire Lifesciences Main Business Overview
13.4.5 Aspire Lifesciences Latest Developments
13.5 Credo Life Sciences
13.5.1 Credo Life Sciences Company Information
13.5.2 Credo Life Sciences Orlistat API Product Portfolios and Specifications
13.5.3 Credo Life Sciences Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Credo Life Sciences Main Business Overview
13.5.5 Credo Life Sciences Latest Developments
13.6 Formosa Laboratories
13.6.1 Formosa Laboratories Company Information
13.6.2 Formosa Laboratories Orlistat API Product Portfolios and Specifications
13.6.3 Formosa Laboratories Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Formosa Laboratories Main Business Overview
13.6.5 Formosa Laboratories Latest Developments
13.7 GPT Pharmaceuticals
13.7.1 GPT Pharmaceuticals Company Information
13.7.2 GPT Pharmaceuticals Orlistat API Product Portfolios and Specifications
13.7.3 GPT Pharmaceuticals Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GPT Pharmaceuticals Main Business Overview
13.7.5 GPT Pharmaceuticals Latest Developments
13.8 Grand Health Industrial
13.8.1 Grand Health Industrial Company Information
13.8.2 Grand Health Industrial Orlistat API Product Portfolios and Specifications
13.8.3 Grand Health Industrial Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Grand Health Industrial Main Business Overview
13.8.5 Grand Health Industrial Latest Developments
13.9 Hanways Chempharm
13.9.1 Hanways Chempharm Company Information
13.9.2 Hanways Chempharm Orlistat API Product Portfolios and Specifications
13.9.3 Hanways Chempharm Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hanways Chempharm Main Business Overview
13.9.5 Hanways Chempharm Latest Developments
13.10 Hasti Aria Shimi
13.10.1 Hasti Aria Shimi Company Information
13.10.2 Hasti Aria Shimi Orlistat API Product Portfolios and Specifications
13.10.3 Hasti Aria Shimi Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hasti Aria Shimi Main Business Overview
13.10.5 Hasti Aria Shimi Latest Developments
13.11 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1)
13.11.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1) Company Information
13.11.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1) Orlistat API Product Portfolios and Specifications
13.11.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1) Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1) Main Business Overview
13.11.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (1) Latest Developments
13.12 Mcneil and Argus pharmaceutical
13.12.1 Mcneil and Argus pharmaceutical Company Information
13.12.2 Mcneil and Argus pharmaceutical Orlistat API Product Portfolios and Specifications
13.12.3 Mcneil and Argus pharmaceutical Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mcneil and Argus pharmaceutical Main Business Overview
13.12.5 Mcneil and Argus pharmaceutical Latest Developments
13.13 Meenaxy Pharma
13.13.1 Meenaxy Pharma Company Information
13.13.2 Meenaxy Pharma Orlistat API Product Portfolios and Specifications
13.13.3 Meenaxy Pharma Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Meenaxy Pharma Main Business Overview
13.13.5 Meenaxy Pharma Latest Developments
13.14 Murli Krishna Pharma
13.14.1 Murli Krishna Pharma Company Information
13.14.2 Murli Krishna Pharma Orlistat API Product Portfolios and Specifications
13.14.3 Murli Krishna Pharma Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Murli Krishna Pharma Main Business Overview
13.14.5 Murli Krishna Pharma Latest Developments
13.15 Pellets Pharma Limited
13.15.1 Pellets Pharma Limited Company Information
13.15.2 Pellets Pharma Limited Orlistat API Product Portfolios and Specifications
13.15.3 Pellets Pharma Limited Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Pellets Pharma Limited Main Business Overview
13.15.5 Pellets Pharma Limited Latest Developments
13.16 Qualitek pharma
13.16.1 Qualitek pharma Company Information
13.16.2 Qualitek pharma Orlistat API Product Portfolios and Specifications
13.16.3 Qualitek pharma Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Qualitek pharma Main Business Overview
13.16.5 Qualitek pharma Latest Developments
13.17 Spansules Pharma
13.17.1 Spansules Pharma Company Information
13.17.2 Spansules Pharma Orlistat API Product Portfolios and Specifications
13.17.3 Spansules Pharma Orlistat API Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Spansules Pharma Main Business Overview
13.17.5 Spansules Pharma Latest Developments
14 Research Findings and Conclusion